|
 |
| home > pmps > spring 2002 > how can advanced speech recognition help during the life cycle of clinical drug trials? |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
Clinical trials - phew! When I first thought about the whole area of clinical trials; the vast amount of data, geographic locations, where and when you might need a licence, where you will find it easy to recruit the right patients...it sent my mind into a spin. But there are lots of ways in which technology such as speech recognition can help reduce cost and time, and improve patient satisfaction.
Speech recognition and its sophistication has vastly improved over the past five years, especially when it comes to the variety of languages now available. Simple choices of responses such as option 1, 2 or 3 and yes or no, has developed into full-blown, speech-synthesised options using natural language speech recognition (NLSR). A telephone call has now evolved to provide assistance from a voice-controlled operator, encouraging use by the elderly with options such as increasing volume or repetition of a sentence.
Natural language speech recognition can be used throughout the life cycle of clinical trials, but let's start at the beginning with the recruitment of patients. Given that it is hard to recruit them in the first place, different countries also have different laws regarding the advertising of clinical trials. In the US, for instance, sponsors of clinical trials can advertise on the Internet or on television. The common denominator, no matter what country, is the call centre that then has to 'screen' potential patients.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
FT Global Pharmaceutical and Biotechnology Conference 2008
2-3 December 2008, The Cumberland, London
FT Global Pharmaceutical and Biotechnology Conference is Europe’s pre-eminent industry event attended by leading executives, government decision makers, investors, analysts and other specialist providers. It provides a unique platform to present new perspectives,’ feel the pulse’ of the industry, and network with peers across the sector.
More info >> |
|
 |
News and Press Releases |
 |
Sandoz Expands its Mammalian Cell Culture Facility in Schaftenau, Austria
1st December, 2008
More info >> |
|
|
